Theacrine in Oral Pouches

Theacrine is 1,3,7,9-tetramethyluric acid, a purine alkaloid structurally related to caffeine. It occurs naturally in Camellia assamica var. kucha, a tea plant, and in cupuacu. The best-known commercial form is TeaCrine, marketed by Compound Solutions. Its own published research describes it as nature-identical: synthesized, and chemically equivalent to the plant compound. That distinction matters on the label, as covered below.

It is sold in a pure grade and a 40% grade marketed as tasteless, where the balance is carrier.

Theacrine is positioned as a companion to caffeine, not a replacement. The supplier describes a longer duration than caffeine, a claimed 4 to 8 hour effect, which is the pitch for pairing a slower-acting compound with a faster caffeine dose in one pouch.

The published pharmacokinetics show the two interact in one direction. In He et al. (Journal of Caffeine Research, 2017), co-dosing 150mg of caffeine raised theacrine's peak blood level and total exposure at a 125mg theacrine dose, with no change in heart rate or blood pressure. Theacrine did not change how the body handled caffeine.

On absorption, be precise. Theacrine belongs to the same small-molecule family as caffeine, which can absorb partly through the oral mucosa, but no published study measures theacrine absorption from a pouch. Treat the pouch as a premeasured, convenient delivery format. Whatever is not absorbed in the mouth is carried by saliva and swallowed.

Supplier dose guidance runs 25 to 300mg, with 50 to 100mg described as typical. Human studies have used 125 to 300mg. The longest safety trial (Taylor et al., JISSN 2016) gave 200 or 300mg a day for 8 weeks to 60 adults; clinical safety markers stayed within normal limits and no habituation was observed. A 2024 study (Gardiner et al., Scientific Reports) compared 100mg with 400mg and found small, non-significant sleep effects at 400mg.

In the pouch market, theacrine is rare. In a PouchMade review of about 36 non-nicotine pouch formulas on major US marketplaces in September 2026, one used theacrine, at a disclosed 5mg per pouch, inside a mushroom-extract nootropic stack rather than a caffeine formula.

PouchMade's standard pouch is 0.6g, with 0.5g and 0.7g formats available, and a typical actives budget of 250-280mg per pouch, about 300mg at most. Filler, flavor, and sweetener make up the rest. Grade decides how much of that actives budget theacrine takes:

In pure grade, the supplier's typical 50-100mg range uses 50-100mg of the budget and leaves roughly 150-230mg for caffeine and anything else (250-280mg minus 50-100mg). A 200mg pure dose leaves only about 50-100mg. At 40% grade, 100mg of theacrine weighs 250mg, which fills a typical budget on its own and leaves at most 50mg under the 300mg ceiling. A 200mg dose at 40% grade weighs 500mg, well past the ceiling, so it does not fit in one pouch.

The 40% grade is marketed as tasteless, which makes it a taste lever that costs actives budget. In a stacked energy pouch, the bitterness budget is usually dominated by caffeine, and mint and wintergreen systems have the strongest in-category precedent for masking bitter actives. Sweetener, cooling agents, and release rate are the other levers.

We found no published stability or hygroscopicity data for theacrine in a pouch base, so stability testing belongs on the finished formula.

Identity is confirmed by infrared spectroscopy plus HPLC retention time against a reference standard. Assay is by HPLC-UV. A published LC-MS/MS method covering caffeine, methylliberine, and theacrine (Wang et al., Journal of Chromatography B, 2020) is the starting point for a lab without an in-house method. A usable certificate of analysis should show:

• The grade (pure or 40%) and the identity of the carrier
• Assay against that grade, by a named HPLC method
• Related substances: caffeine, methylliberine, and 1,3,7-trimethyluric acid
• Heavy metals and microbial results

Theacrine is a post-DSHEA ingredient. As of September 2026, FDA's posted list of new dietary ingredient notifications has no entry for theacrine, and there is no FDA GRAS notice. The supplier states self-affirmed GRAS and a Health Canada NPN, and does not claim an NDI notification. Self-affirmed GRAS is a food-use determination made by the supplier, not an FDA review and not an NDI notification. Whether theacrine qualifies without one is a legal judgment for regulatory counsel.

Labeling needs care. Because the commercial material is synthesized, do not label it "from kucha tea" unless botanical origin is documented. FDA's DMAA enforcement, which turned on the lack of reliable evidence that the compound occurs naturally in plants, is the cautionary precedent for any "found in tea" claim.

Theacrine is not on California's Prop 65 list, no FDA warning letters naming it were found in FDA's current index, and Amazon's dietary supplement policy has no theacrine-specific restriction. Claims stay in structure/function territory, such as "supports energy," with the standard DSHEA disclaimer. For the broader picture, see Are Caffeine Pouches FDA Regulated?

Theacrine fits energy pouch formulas, stacked with caffeine at 0-200mg per pouch, and sometimes alongside methylliberine. Caffeine and theacrine share the same 250-300mg actives budget: a 200mg caffeine pouch leaves about 50-100mg for pure-grade theacrine, or only about 20-40mg of theacrine in 40% grade. Because grade, dose, and the caffeine interaction all have to be designed together, theacrine formulas are developed through custom formulation in PouchMade's FDA-registered, GMP-certified facility in Dallas, Texas, where pouches are produced as dietary supplements under 21 CFR 111 and packed 15 to a can.